ARTICLE | Clinical News
NiCord: Completed Phase I/II enrollment
September 24, 2012 7:00 AM UTC
Gamida Cell completed enrollment of 11 patients in an open-label, U.S. Phase I/II trial evaluating co-transplantation of NiCord in combination with an unexpanded cord blood unit following myeloablativ...